Paul Turk

Senior Partner

Paul is a highly experienced Program/Project Manager working across many industries including Mining, Oil & Gas, ISP, IT, Telco, Finance and Manufacturing. He combines solid understanding of business objectives, a strong technical aptitude and exceptional problem solving and analytical skills. He’s able to lead, or work within a team across many technical disciplines in both small and large scale projects.


Originally from Melbourne, Paul worked for Suncor as an International & Offshore Telecom Project Manager, delivering Telecom and IT strategy and services in remote sites located in Syria, Libya, Norway, UK, Europe and Trinidad and Tobago


In 2014 he joined Straxia, continuing to support Suncor across its International sites and working with clients in the Financial Services and Private Healthcare sectors for network transformation and project delivery. He then commenced roles within Verizon UK supporting its Post Office activities.


Paul is a keen sports fan with a passion for Australian rules football, cricket and golf.

Industry insights


Photo of all the Top21 winners at the #21toWatch awards 2026, held at the Glasshouse in Cambridge.
by Jeremy Griggs • 18 November 2026
As #21toWatch 2027 opens, we look at how 147 winners from Cambridge’s innovation ecosystem have raised over £1bn and earned awards, fellowships, and more | READ FULL ARTICLE
Abstract technology image with the words 'Research Preview' overlaid.
by Charlotte Patrick • 17 November 2026
CAMBRIDGE AIQ | How can operators scale agentic AI towards autonomous networks? Our report sets out a five-stage roadmap, the key risks, and a framework for Stage 4 | READ PREVIEW & PURCHASE REPORT
16 November 2026
10 November 2026 – London – IThe search is on for the next generation of game-changing founders, pioneering companies and breakthrough innovations as #21toWatch opens the nominations window for its prestigious 2027 awards. Run by Cambridge Management Consulting, #21toWatch has a proven track record of spotlighting emerging talent and technologies from Cambridge and across the East of England - ventures with the potential to translate ambitious ideas into meaningful commercial and societal impact. Submissions typically span all areas of cutting-edge emerging innovation including artificial intelligence, deep tech, medtech, life sciences, biotechnology and climate technology. Some of the exciting entries already received for 2027 are as follows: In the ‘People’ category, biochemist, Dr Irina Gostimskaya, co-founder and CEO of Cambridge Molecular Computers, is a leading authority on reading, writing, and editing DNA. With her team at Cambridge Molecular Computers, she is building an alternative computing platform beyond silicon, using the programmability of DNA to solve previously intractable problems. Trading space for time, a DNA computer enables a desktop machine to outperform the world’s current fastest supercomputer, while consuming only a fraction of the energy. In the ‘Company’ category, pioneering femtech startup, Avline Health is building a pioneering intelligent clinical decision-support platform that combines individual patient risk assessment with evidence-informed treatment recommendations for genitourinary syndrome of menopause (GSM) after breast cancer. Combining vaginal microbiome sequencing, treatment history and longitudinal health data, Avline Health aims to provide clinicians with an objective severity score and a contraindication-aware treatment match, instead of a guess. CEO and co-founder, Dr. Josiane Chuisseu told us: “Vaginal microbiome testing does already exist - but nobody's built it for oncology before, and it’s very much needed. Up to 70% of breast cancer survivors develop genitourinary syndrome of menopause (GSM), a chronic and progressive condition caused by a drop in oestrogen levels - but it's chronically underdiagnosed because assessment still relies on subjective exams, and undertreated because clinicians are often too cautious to prescribe hormone therapy in cancer patients even when it's now shown to be safe. “As a result, two-thirds of women get the wrong diagnosis, and the treatments they do get are only effective less than 20% of the time." Meanwhile, in the ‘Things’ category, Metcycle is developing a scalable, energy-efficient technology to transform lithium-ion battery black mass into high-value critical materials. By addressing the industry’s key separation bottleneck, Metcycle aims to reduce reliance on energy-intensive and chemical-heavy recycling routes, enabling more economical recovery of battery metals while strengthening Europe’s domestic supply of critical raw materials. The 2027 #21toWatch campaign follows a year of incredible innovation across the region, with last year’s winning cohort continuing to make significant progress across investment, commercialisation and innovation: 2026 #21toWatch winner, Memorify has launched its Yoree memory platform following an oversubscribed £420k pre-seed investment round and a waitlist of more than 5,000 prospective users. Elsewhere, fellow winner, Loop52 has been selected for a share of a £2.7m Government-backed automotive innovation funding programme while another 2026 winner, Myonerv has won a £100k Innovate UK grant to advance clinical testing of its wearable stroke-rehabilitation technology, and 2026 winner, Cyclana Bio, which aims to find a cure for endometriosis, has secured approval for a 500-patient clinical study. Tim Passingham, founder and executive chairman of Cambridge Management Consulting, said: “Together, these achievements demonstrate the breadth of progress being made by the #21toWatch community, from attracting investment and bringing products to market to advancing clinical research and developing technologies with significant industrial potential. “#21toWatch is all about the importance of identifying promising innovators early and helping them gain the recognition and connections needed to scale. However, we are delighted that the impact of #21toWatch extends well beyond the awards.” Collectively, past winners have now raised more than £1billion, underlining the scale of the technical ambition among the ventures, and the importance of bringing such innovators to the attention of investors, customers and the wider business community. The #21toWatch shortlist – judged by a panel of independent judges - will be announced on 3 February 2027, with the final Top21, selected across three categories: People, Companies and Things, unveiled at an awards ceremony at Pembroke College, Cambridge, on 11 March 2027. Founders, companies and innovators can submit their own nominations through the #21toWatch website at https://www.21towatch.com/. Deadline for entries is 8 January 2027. Nominations are also invited from investors, universities and others across the innovation ecosystem. The judging process considers innovation, the challenge being addressed, influence, viability and memorability. Marks & Clerk returns as a premium sponsor of the 2027 #21toWatch campaign. Matthew Pinney, Office Managing Partner, Marks & Clerk Cambridge, said: “Cambridge has an extraordinary depth of entrepreneurial talent, and #21toWatch provides a valuable platform for recognising those innovators turning ambitious ideas into businesses with real commercial potential. We look forward to meeting this year’s cohort, learning more about their ambitions, and helping them protect and maximise the value of their innovations through intellectual property as they contribute to the region’s continuing success as a centre for innovation.” Further sponsors and the full judging panel will be announced shortly.
Big Ben and London cityscape at night – neon overlay
11 November 2026
Cambridge MC acquires Alpine Resourcing, a London-based public sector specialist, extending its reach across central and local government in the UK | READ PRESS RELEASE
A representation of agent boxes (prompts) linked into a workflow on a computer screen.
by Charlotte Patrick • 9 November 2026
RESEARCH & ANALYSIS | Cambridge AIQ assesses 13 vendors delivering agentic AI for service assurance, comparing four distinct strategies and the key factors operators must weigh | READ PREVIEW & PURCHASE REPORT
Audience at the recent launch event for the #21toWatch 2027 awards at the Glasshouse, Cambridge.
9 November 2026
A new monthly event series for scaleup founders, investors, and advisers at The Glasshouse, Cambridge. Starts 26 November with CMR Surgical’s Martin Frost CBE | READ FULL PRESS RELEASE
SHOW MORE